![Michael M. Kitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael M. Kitt
Directeur Général chez
Axalbion Therapeutics Ltd.
Profil
Michael M.
Kitt currently works at Axalbion Therapeutics Ltd., as Chief Executive Officer & Director.
Dr. Kitt also formerly worked at Attenua, Inc., as President, CEO, CFO & Director from 2018 to 2019, COR Therapeutics, Inc., as Vice President-Clinical Research from 1993 to 2002, The Upjohn Co., as Vice President-International Clinical Research, Portola Pharmaceuticals LLC, as Chief Medical Officer & Senior Vice President from 2011 to 2013, Afferent Pharmaceuticals, Inc., as Chief Medical Officer, Innoviva, Inc., as Senior Vice President-Development from 2002 to 2008, Nuon Therapeutics, Inc., as Chief Medical Officer from 2008 to 2011, and Sterling Winthrop Pharmaceuticals Research Center, as Senior Vice President-Clinical Research.
Dr. Kitt received his undergraduate degree from New York University Tandon School of Engineering and doctorate degree from New York University School of Medicine.
Postes actifs de Michael M. Kitt
| Sociétés | Poste | Début |
|---|---|---|
Axalbion Therapeutics Ltd.
 Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Directeur Général | 01/11/2019 |
Anciens postes connus de Michael M. Kitt
| Sociétés | Poste | Fin |
|---|---|---|
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Directeur Général | 01/11/2019 |
| PORTOLA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 16/08/2013 |
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Directeur Technique/Scientifique/R&D | 01/06/2011 |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Directeur Technique/Scientifique/R&D | 25/02/2011 |
| INNOVIVA, INC. | Corporate Officer/Principal | 20/06/2008 |
Formation de Michael M. Kitt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Health Technology |
Sterling Winthrop Pharmaceuticals Research Center | |
New York University Tandon School of Engineering
 New York University Tandon School of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attenua, Inc.
Attenua, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Health Technology |
